POWERED BY

Prestigious ERC Synergy Grant awarded for research on transfer RNA

PublishedNovember 19, 2026

An international research team with researchers from the University of Bern is investigating how chemical modifications of transfer RNA (tRNA) affect protein production and the functioning of human cells.

The “LifeOfTRNA” project is expected to begin in May 2027 and will run for six years. It is led by Professor Sebastian Glatt of the University of Veterinary Medicine in Vienna, Professor Janusz Bujnicki of the International Institute of Molecular and Cell Biology in Warsaw, Professor Sebastian Leidel (in picture) of the University of Bern, and Dr. Carine Tisné of the French National Center for Scientific Research (CNRS).

The project, “LifeOfTRNA,” has been awarded an ERC Synergy Grant worth nearly 10 million euros. The research is expected to contribute to a better understanding of diseases associated with disruptions in these processes.

ERC Synergy Grants are among the most prestigious funding instruments offered by the European Research Council (ERC). They are awarded under the European Union’s Horizon Europe research and innovation program. Of the 957 proposals submitted under the 2026 ERC Synergy Grant call, approximately five percent were selected for funding.

Advancing cutting-edge research through complementary expertise

ERC Synergy Grants support small groups of two to four researchers who work together on challenging research questions that could not be addressed by individual research groups working alone. The grants enable researchers to carry out their projects over a period of six years.

The “LifeOfTRNA” project will receive nearly 10 million Euros in total, including 2.5 million Euros for the research group led by Professor Sebastian Leidel in the Department of Chemistry, Biochemistry and Pharmaceutical Sciences at the University of Bern. Professor Leidel is participating in the project as an equal principal investigator. “We are delighted that Sebastian Leidel and his team are contributing their expertise to this internationally significant research project,” says Professor Nadia Mercader, designated Vice President for Research and Innovation at the University of Bern. “The ERC Synergy Grant confirms the excellence of his research group and the University of Bern’s important contribution to understanding fundamental processes in human cells.”

Molecular model of a folded RNA structure with grey atoms and coloured molecular groups on a white background

Investigating the role of tRNAs in protein production

Proteins perform close to all functions in the human body. To produce them, cells use the genetic information encoded in DNA. Ribosomes read this information and assemble proteins from individual building blocks called amino acids. Sebastian Leidel explains the process using an analogy: “Put simply, DNA is the blueprint, the ribosome is the production machine, and tRNA – transfer RNA – is the delivery service. It brings the required amino acids to the ribosome, where they are assembled into a protein in the correct order.” To perform their functions, tRNAs undergo chemical modifications at specific sites after they are produced. These so-called tRNA modifications help them adopt the correct shape and reliably deliver their amino acids to the ribosome. If these modifications are missing, the tRNA function is impaired, and protein production may slow down or become inaccurate.

Combining expertise to study tRNA

Building on this foundation, the international research team is investigating three key questions: How do tRNA modifications affect the structure and stability of tRNAs? How do they shape interactions between tRNAs and other molecules? And how do they affect protein production and the functioning of cells? The four research groups are combining biochemical and cellular experiments with structural biology, high-resolution sequencing, and computational modeling. “Each of the four research groups brings a different perspective and specialized methods to the project” says Leidel. “By combining these approaches, we can study tRNA modifications at different levels – from individual chemical changes to their effects on ribosomes and entire cells.”

Ribosome profiling in living cells

The team at the University of Bern, led by Sebastian Leidel, focuses on how tRNA modifications affect protein production and the functioning of human cells. To do so, the researchers are generating cell lines that lack individual enzymes responsible for chemically modifying tRNAs. They then analyze how these changes affect tRNAs, ribosomes, and protein production. “For many years, we have used high-resolution sequencing methods and a technique known as ribosome profiling,” Leidel explains. He adds: “Important groundwork in this area was carried out as part of the now-completed National Center of Competence in Research (NCCR) RNA & Disease funded by the Swiss National Science Foundation (see information box).” Sequencing methods reveal which RNA molecules are present in a cell and which genetic information is being used to produce proteins. Ribosome profiling is used to determine which genetic instructions ribosomes are currently reading, how quickly they are progressing, and where protein production is slowing or stalling. Leidel explains: “These methods allow us to trace how the absence of specific tRNA modifications affects protein production. This then enables us to link molecular changes in tRNAs to changes in the functioning of entire cells.” Leidel concludes: “Similar processes also play a role in many degenerative diseases. We hope that our research will make a concrete contribution to a better understanding of the mechanisms underlying these diseases.”

Source